Michael K. Samson

1.4k total citations
51 papers, 981 citations indexed

About

Michael K. Samson is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael K. Samson has authored 51 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 15 papers in Molecular Biology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael K. Samson's work include Lung Cancer Research Studies (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Cancer therapeutics and mechanisms (8 papers). Michael K. Samson is often cited by papers focused on Lung Cancer Research Studies (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Cancer therapeutics and mechanisms (8 papers). Michael K. Samson collaborates with scholars based in United States, Pakistan and Nigeria. Michael K. Samson's co-authors include Laurence H. Baker, Ronald L. Stephens, Lynn G. Feun, Saul E. Rivkin, Glenn Cummings, Albert F. LoBuglio, John J. Costanzi, Edmund A. Gehan, Stephen E. Jones and Paul V. Woolley and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Michael K. Samson

46 papers receiving 883 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael K. Samson United States 20 361 325 294 237 132 51 981
Claude Merrin United States 20 264 0.7× 612 1.9× 491 1.7× 144 0.6× 52 0.4× 56 1.1k
Michael P. Corder United States 16 509 1.4× 789 2.4× 231 0.8× 206 0.9× 153 1.2× 46 1.7k
Eligio Grigoletto Italy 14 375 1.0× 119 0.4× 221 0.8× 91 0.4× 65 0.5× 54 745
DeVita Vt United States 14 323 0.9× 475 1.5× 199 0.7× 85 0.4× 100 0.8× 52 1.1k
Bitran Jd United States 14 431 1.2× 102 0.3× 221 0.8× 272 1.1× 58 0.4× 33 1.2k
Maria Koch Canada 12 263 0.7× 176 0.5× 123 0.4× 107 0.5× 26 0.2× 28 644
Martine George United States 9 277 0.8× 106 0.3× 298 1.0× 120 0.5× 28 0.2× 16 898
Philip A. Salem United States 18 475 1.3× 333 1.0× 383 1.3× 110 0.5× 54 0.4× 36 1.3k
Simona Secondino Italy 18 687 1.9× 168 0.5× 227 0.8× 206 0.9× 58 0.4× 59 1.2k
James P. O'Brien United States 14 458 1.3× 223 0.7× 192 0.7× 169 0.7× 196 1.5× 37 1.2k

Countries citing papers authored by Michael K. Samson

Since Specialization
Citations

This map shows the geographic impact of Michael K. Samson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael K. Samson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael K. Samson more than expected).

Fields of papers citing papers by Michael K. Samson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael K. Samson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael K. Samson. The network helps show where Michael K. Samson may publish in the future.

Co-authorship network of co-authors of Michael K. Samson

This figure shows the co-authorship network connecting the top 25 collaborators of Michael K. Samson. A scholar is included among the top collaborators of Michael K. Samson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael K. Samson. Michael K. Samson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Samson, Michael K., et al.. (2025). Patterns of Ear Morbidities Among Pediatric Age Group: A Tertiary Care Hospital-Based Study. Cureus. 17(5). e83958–e83958.
3.
Slavik, Milan, Kenneth J. Kopecky, Vernon K. Sondak, John B. Craig, & Michael K. Samson. (1993). Evaluation of amonafide in disseminated malignant melanoma. Investigational New Drugs. 11(2-3). 223–226. 5 indexed citations
4.
Kish, Julie A., Michael K. Samson, Daniel D. Von Hoff, et al.. (1991). Evaluation of fludarabine phosphate in malignant melanoma. Investigational New Drugs. 9(1). 105–108. 10 indexed citations
5.
Woźniak, Agnieszka, Michael K. Samson, E. David Crawford, et al.. (1991). A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.. Journal of Clinical Oncology. 9(1). 70–76. 31 indexed citations
6.
Whitehead, Robert P., Kenneth J. Kopecky, Michael K. Samson, et al.. (1991). Phase II Study of Intravenous Bolus Recombinant Interleukin-2 in Advanced Malignant Melanoma: Southwest Oncology Group Study. JNCI Journal of the National Cancer Institute. 83(17). 1250–1252. 35 indexed citations
7.
Dubaybo, Basim A., Michael K. Samson, & Richard W. Carlson. (1991). The Role of Physician-Assistants in Critical Care Units. CHEST Journal. 99(1). 89–91. 35 indexed citations
8.
Samson, Michael K., Ernest C. Borden, H. J. Wanebo, et al.. (1987). Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study.. Journal of Clinical Oncology. 5(1). 86–91. 58 indexed citations
9.
Pazdur, Richard, Michael K. Samson, & Laurence H. Baker. (1987). Aclacinomycin A Phase II Evaluation in Advanced Soft Tissue Sarcoma. American Journal of Clinical Oncology. 10(3). 237–239. 2 indexed citations
10.
11.
12.
Pazdur, Richard, Michael K. Samson, & Laurence H. Baker. (1987). Fludarabine Phosphate Phase II Evaluation in Advanced Soft-Tissue Sarcomas. American Journal of Clinical Oncology. 10(4). 341–343. 13 indexed citations
13.
Samson, Michael K., Saul E. Rivkin, Stephen E. Jones, et al.. (1984). Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group study. Cancer. 53(5). 1029–1035. 150 indexed citations
14.
Decker, David A., Michael K. Samson, Charles D. Haas, & Lawrence Baker. (1984). Phase II clinical evaluation of AZQ in adenocarcinoma of the lung. American Journal of Clinical Oncology. 7(4). 353–356. 1 indexed citations
15.
Samson, Michael K., Baker Lh, Glenn Cummings, et al.. (1982). Clinical trial of chlorozotocin, DTIC, and dactinomycin in metastatic malignant melanoma.. PubMed. 66(2). 371–3. 3 indexed citations
16.
Feun, Lynn G., Michael K. Samson, & Ronald L. Stephens. (1980). Vinblastine (VLB), bleomycin (BLEO), cis-diamminedichloroplatinum (DDP) in disseminated extragonadal germ cell tumors. A southwest oncology group study. Cancer. 45(10). 2543–2549. 85 indexed citations
17.
Samson, Michael K., et al.. (1976). Phase 1-11 study of DTIC and cyclocytidine in disseminated malignant melanoma.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 60(9). 1369–71. 2 indexed citations
18.
Buroker, T, et al.. (1976). Hepatic artery infusion of 5-FUDR after prior systemic 5-fluorouracil.. PubMed. 60(9). 1277–9. 18 indexed citations
19.
Tranum, Bill L., Arthur Haut, Saul E. Rivkin, et al.. (1975). A phase II study of methyl CCNU in the treatment of solid tumors and lymphomas: A Southwest oncology group study. Cancer. 35(4). 1148–1153. 26 indexed citations
20.
Woolley, Paul V., et al.. (1963). A phenotypic female with 49 chromosomes, presumably XXXXX. The Journal of Pediatrics. 63(6). 1099–1103. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claude Merrin Breakdown of academic impact, for papers by Michael P. Corder Breakdown of academic impact, for papers by Eligio Grigoletto Breakdown of academic impact, for papers by DeVita Vt Breakdown of academic impact, for papers by Bitran Jd Breakdown of academic impact, for papers by Maria Koch Breakdown of academic impact, for papers by Martine George Breakdown of academic impact, for papers by Philip A. Salem Breakdown of academic impact, for papers by Simona Secondino Breakdown of academic impact, for papers by James P. O'Brien
Rankless by CCL
2026